Previous close | 510.40 |
Open | 511.60 |
Bid | 510.00 x 0 |
Ask | 520.00 x 0 |
Day's range | 511.60 - 521.40 |
52-week range | 308.60 - 599.40 |
Volume | |
Avg. volume | 210,450 |
Market cap | 37.068B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 57.88 |
EPS (TTM) | 8.88 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 4.00 (0.78%) |
Ex-dividend date | 13 May 2024 |
1y target est | 715.25 |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...